Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more


disease icon Neuroendocrine Tumor Research Foundation

The mission of the Neuroendocrine Tumor Research Foundation (NETRF) is to fund research to discover cures and more effective treatments for carcinoid, pancreatic, and related neuroendocrine cancers.

The NETRF believes that creating and maintaining a highly collaborative NET research community is pivotal in accelerating progress in the diagnosis and treatment of neuroendocrine cancers. As such, NETRF strongly encourages its funded scientists to make their published materials and resources available to academic researchers around the world.

The NETRF is grateful for the generous support of philanthropic individuals and foundations, who share in their vision to accelerate scientific discovery that will help create new and more effective therapies for these tumors. The NETRF encourages others to join their cause.

Browse the available plasmids from the NETRF-funded investigators listed below.

Depositing Principal Investigators (PIs)

PI Institution NETRF Project Title
Hans Clevers Hubrecht Institute Modeling Neuroendocrine Tumors Using Adult Stem Cell-Derived Organoids
Matthew Meyerson Dana-Farber Cancer Institute Finding the Causes of Small Intestinal Neuroendocrine Tumors
Ramesh Shivdasani Dana-Farber Cancer Institute Epigenetic Regulators of Intestinal Endocrine Cells and Carcinoid Tumors
Qiao Zhou Harvard University Epigenetic Regulators of Intestinal Endocrine Cells and Carcinoid Tumors
Bradley Bernstein Broad Institute Identifying Altered Epigenetic States and Drivers in Intestinal Carcinoid and Pancreatic Neuroendocrine Tumors